Collection-image

TOPICAL COLLECTIONS

Management of the Sars-Cov-2 Pandemic: Protocols for Diagnostics, Vaccines, and Treatment Options

Submit Abstract

Guest Editor

Eleonora Nicolai

Eleonora Nicolai

University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy

Dr. Eleonora Nicolai carries out her research activities as a Scientific Technician at the Department of Experimental Medicine of the University of Rome Tor Vergata, and is responsible for the following research lines:  1) Optimization and validation of a "fast screening" system for bacteriuria in urine, through the use of fluorescence probes. (Collaboration with Prof. Weian Zhao, of the University of Irvine, CA, USA) 2) Development and clinical validation of a protocol for the rapid antibiogram. (Collaboration with Prof. Enrico Gratton, UCI, Irvine, CA, USA and ASI, Milan, Italy) 3) Study of the effects on the activity of metal proteases by orthophosphoric acid for purposes related to dental practice. (Collaboration with the Dept. of Clinical Sciences and Translational Medicine) 4) Study of a quantitative detection system of microplastics in water. (Collaboration with the Department of Environmental Engineering, University of Rome Tor Vergata) 5) Study aimed at creating a microfluidic system for the identification of contaminants in water of a microbiological or polymeric nature with a high molecular weight (microplastics). (Collaboration with Industrial Engineering Department, University of Rome Tor Vergata; Resind srl, Rome, Italy) 6) Study of the structure and function of biological macromolecules with particular regard to the problem of aggregation and behavior of proteins under high pressure 7) Use of the “Fluorescence Correlation Spectroscopy” technique applied to the study of multimeric systems. She has expertise in using the following spectroscopic techniques: static and dynamic fluorescence with time-resolved phase and modulation techniques; static fluorescence and absorption at high pressures; circular dichroism; confocal microscopy with two-photon laser excitation source; and optical and fluorescence microscopy.

Collection Overview

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019, raising a major health concern.

To date, there are no specific and completely effective drugs to the disease. Highly sensitive laboratory diagnostics are therefore critical for controlling the rapidly evolving COVID-19 pandemic, as well as the optimization of clinical care, infection control, and public health interventions. Rapid, accurate and accessible diagnostics are needed for the early detection of pathogens in the preclinical and asymptomatic stages and throughout the follow-up period, until their elimination. Optimization of clinical care and infection control are necessary to limit the disease and contain the impact on hospital workflow; also, public health interventions play a crucial role in preventing the spread of the contagion.

This Methods Collection invites protocols that include, but are not limited to molecular and immunoassay-based tests, new rapid point-of-care diagnostic methods, techniques to identify asymptomatic carriers of COVID-19 during the early stage of infection, new therapeutic approaches or ongoing drug discovery efforts, and finally, management protocols to promptly isolate infected persons. The goal is to present various methods, tools, or technologies in one place that can contribute towards ending the pandemic worldwide.

Articles

Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy
8:07

Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy

0 Views

•

2024

•